VIR
#2052
Vir Biotechnology, Inc. - Common Stock
10.9 4 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.02%
Variación mensual
+25.17%
Variación en los últimos 6 meses
+23.62%
Cambio anual
+82.94%
Cierres anteriores
10.8 3
Open
10.9 4
Mínimo
10.9 4
Máximo
10.9 4
Volumen
134
Financials
- Market Capitalization 1.85 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.48
Relación precio/flujo de caja
5.42
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2048 |  IMCR Immunocore Holdings plc - American Depositary Shares | 36.32 USD | -0.82% | -0.49% | +7.46% | +8.48% | 1.87 B USD | ||
| 2050 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.69 USD | -1.39% | -5.95% | -3.40% | +96.21% | 1.85 B USD | ||
| 2068 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.40 USD | +1.80% | +3.98% | +12.21% | -25.93% | 1.82 B USD | ||
| 2073 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 122.74 USD | -0.54% | +22.74% | +49.94% | +52.32% | 1.81 B USD |